News & Publications

Questions? Contact us at info@nkartatx.com

Publications & References


Natural Killer Cells May Be Scaled and Engineered as a Next Generation, Off-the-Shelf Cell Therapy for Cancer
Cell & Gene Therapy Insights, Trager, October 2019


The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
Front Immunol, Veluchamy et al, May 2017


Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma
Cancer Immunol Res , Kamiya, Chang, Campana, July 2016


Ex Vivo-Expanded Natural Killer Cells Demonstrate Robust Proliferation in Vivo in High-Risk Relapsed Multiple Myeloma Patients
J Immunother, Szmania et al, January 2015


Autonomous Growth and Increased Cytotoxicity of Natural Killer Cells Expressing Membrane-Bound interleukin-15
Blood, Imamura et al, August 2014


Clearance of Acute Myeloid Leukemia by Haploidentical Natural Killer Cells Is Improved Using IL-2 Diphtheria Toxin Fusion Protein
Blood, Bachanova et al, June 2014


A Chimeric Receptor With NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor Cells
Cancer Res, Chang et al, March 2013


Natural Killer Cell Reprogramming With Chimeric Immune Receptors
Methods Mol Biol, Shimasaki, Campana, 2013


Cytotoxicity of Activated Natural Killer Cells Against Pediatric Solid Tumors
Clin Cancer Res, Cho et al, August 2010


Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells
Blood, Imai, Iwamoto, Campana, March 2008